Toggle Main Menu Toggle Search

Open Access padlockePrints

A Phase 1/2A trial of idroxioleic acid: First-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma

Lookup NU author(s): Julieann Sludden, Professor Gareth Veal, Professor Ruth Plummer

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Publication metadata

Author(s): Lopez J, Lai-Kwon J, Molife R, Welsh L, Tunariu N, Roda D, Fernandez-Garcia P, Lladó V, McNicholl A, Roselló C, Taylor R, Azaro A, Ahnert JR, Sludden J, Veal G, Plummer R, Urruticoechea A, Lahuerta A, Mujika K, Escriba P

Publication type: Article

Publication status: Published

Journal: British Journal of Cancer

Year: 2023

Volume: 129

Pages: 811-818

Print publication date: 21/09/2023

Online publication date: 14/07/2023

Acceptance date: 01/06/2023

Date deposited: 19/09/2023

ISSN (print): 0007-0920

ISSN (electronic): 1532-1827

Publisher: Nature

URL: https://doi.org/10.1038/s41416-023-02356-1

DOI: 10.1038/s41416-023-02356-1


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
CRUK
H2020 Framework Programmes
NHS England

Share